Melissa Leccese, - Audiologist in Fort Campbell, KY

Melissa Leccese, is a Audiologist based in Fort Campbell, Kentucky. Melissa Leccese is licensed to practice in Pennsylvania (license number AT001054L) and her current practice location is 650 Joel Dr, Fort Campbell, Kentucky. She can be reached at her office (for appointments etc.) via phone at (270) 798-8372.

NPI number for Melissa Leccese is 1396879425 and her current mailing address is 650 Joel Dr, Fort Campbell, Kentucky. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1396879425.

Contact Information

Melissa Leccese,
650 Joel Dr,
Fort Campbell, KY 42223-5318
(270) 798-8372
(270) 956-0180



Healthcare Provider's Profile

Full NameMelissa Leccese
GenderFemale
SpecialityAudiologist
Location650 Joel Dr, Fort Campbell, Kentucky
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1396879425
  • Provider Enumeration Date: 03/14/2007
  • Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Melissa Leccese such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1396879425NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
231H00000XAudiologist AT001054L (Pennsylvania)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melissa Leccese is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Melissa Leccese,
650 Joel Dr,
Fort Campbell, KY 42223-5318

Ph: (270) 798-8372
Melissa Leccese,
650 Joel Dr,
Fort Campbell, KY 42223-5318

Ph: (270) 798-8372

News Archive

FDA ODAC to review Onyx's NDA for carfilzomib

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review the company's new drug application (NDA) for carfilzomib for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies. ODAC will review carfilzomib at its meeting on June 20, 2012.

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma.

iPierian to participate in $3.7 million NIH grant awarded to The Johns Hopkins University

iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that it has been selected to participate in a $3.7 million National Institutes of Health (NIH) Grand Opportunities (GO) grant awarded to The Johns Hopkins University.

Prostate brachytherapy causes fewer side effects than surgery

Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.

Soy nuts lower blood pressure in postmenopausal women

Substituting soy nuts for other protein sources in a healthy diet appears to lower blood pressure in postmenopausal women, and also may reduce cholesterol levels in women with high blood pressure, according to a report in the May 28 issue of Archives of Internal Medicine.

Read more News

› Verified 8 days ago


Audiologist in Fort Campbell, KY

Dr. Rodney Kenneth Brannan, AU.D.
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 650 Joel Dr, Fort Campbell, KY 42223
Phone: 270-798-8106    
Ms. Pamela Collins, M.A., CCC-A
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 650 Joel Dr, Fort Campbell, KY 42223
Phone: 270-412-9110    
Elizabeth Lee, SLP/A
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 650 Joel Dr, Fort Campbell, KY 42223
Phone: 270-798-8106    
Dr. Christopher Lawson,
Audiologist
Medicare: Medicare Enrolled
Practice Location: 5979 Desert Storm Ave, Audiology, Lapointe Health Clinic, Fort Campbell, KY 42223
Phone: 270-412-9110    
Dr. Sharleen Marie Rupp, AU.D.
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 5979 Desert Storm Ave, Fort Campbell, KY 42223
Phone: 270-412-9110    Fax: 270-412-9131
Mrs. Amy A Blank, CCC-A
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 650 Joel Dr, Fort Campbell, KY 42223
Phone: 270-412-7804    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.